Actively Recruiting
The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations
Led by Wael Elbanna Clinic · Updated on 2024-06-25
99
Participants Needed
1
Research Sites
226 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Our study aims to evaluate the efficacy of intracapsular injection of Terlipressin versus Carbetocin injection on hemoglobin level in women undergoing abdominal laparoscopic myomectomy. Moreover, to evaluate their efficacy in decreasing blood loss on operative time and to describe the injection sequelae for the same population. This clinical study will be conducted in compliance with the clinical study protocol and applicable regulatory requirements.
CONDITIONS
Official Title
The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 16-45 years
- Suitable medical condition for laparoscopic surgery with largest myoma 15 cm or less
- Baseline hemoglobin of 9 g/dl or higher
- No contraindications to glyopressin or carbetocin use
- Presence of myoma-related symptoms such as pelvic pressure, pain, heavy menstrual bleeding, or infertility
- Not pregnant at time of study entry (negative pregnancy test or last menstrual period within 4 weeks)
You will not qualify if you...
- Previous myomectomy surgery
- History of bleeding disorders
- Current use of anticoagulation therapy
- History of uncontrolled ischemic heart disease
- Any pelvic abnormalities requiring additional surgery
- Treatment with GnRH agonist or ulipristal acetate within 3 months before surgery
- Unable to understand or provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Wael El Banna Clinic
Maadi, Egypt
Actively Recruiting
Research Team
W
Wael El Banna
CONTACT
E
Esraa mohammad
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here